Golden State Wealth Management LLC Grows Stake in Relx Plc (NYSE:RELX)

Golden State Wealth Management LLC raised its stake in Relx Plc (NYSE:RELX) by 100.0% during the first quarter, HoldingsChannel reports. The fund owned 588 shares of the technology company’s stock after buying an additional 294 shares during the period. Golden State Wealth Management LLC’s holdings in Relx were worth $30,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Transce3nd LLC purchased a new stake in shares of Relx in the fourth quarter worth $40,000. Brown Brothers Harriman & Co. grew its stake in shares of Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company’s stock worth $44,000 after acquiring an additional 662 shares during the last quarter. Private Trust Co. NA grew its stake in shares of Relx by 19.2% in the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company’s stock worth $56,000 after acquiring an additional 199 shares during the last quarter. Redwood Investments LLC purchased a new stake in shares of Relx in the fourth quarter worth $120,000. Finally, Steward Partners Investment Advisory LLC grew its stake in shares of Relx by 50.2% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 2,751 shares of the technology company’s stock worth $125,000 after acquiring an additional 919 shares during the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.

Relx Trading Down 2.4%

Relx stock opened at $52.60 on Thursday. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. Relx Plc has a one year low of $43.45 and a one year high of $56.33. The stock has a market capitalization of $98.77 billion, a PE ratio of 28.28, a price-to-earnings-growth ratio of 3.25 and a beta of 0.83. The business’s fifty day moving average is $53.82 and its 200 day moving average is $50.47.

Wall Street Analyst Weigh In

RELX has been the topic of several recent analyst reports. Barclays raised Relx from an “equal weight” rating to an “overweight” rating in a research report on Friday, March 14th. The Goldman Sachs Group initiated coverage on Relx in a research report on Wednesday, March 26th. They set a “buy” rating on the stock. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a research report on Wednesday, April 16th. One analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy”.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.